palmidrol has been researched along with Cystitis in 3 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| " (1) The therapeutic effects of the cannabinoid anandamide and the putative CB2 agonist palmitoylethanolamide were tested in a model of persistent visceral pain (turpentine inflammation of the urinary bladder)." | 7.70 | The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. ( Hasnie, FS; Jaggar, SI; Rice, AS; Sellaturay, S, 1998) |
| " In inflamed bladders, URB937 had a U-shaped dose-response curve; following an initial cannabinoid receptor type 1-mediated reduction in pain responses and normalisation of bladder reflex activity, URB937 gradually increased both pain responses and bladder reflex activity through the transient receptor potential ion channel subfamily V member 1." | 5.56 | Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats. ( Charrua, A; Cruz, F; Marczylo, T; Matos, R; Nagy, I; Oliveira, R, 2020) |
| " (1) The therapeutic effects of the cannabinoid anandamide and the putative CB2 agonist palmitoylethanolamide were tested in a model of persistent visceral pain (turpentine inflammation of the urinary bladder)." | 3.70 | The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. ( Hasnie, FS; Jaggar, SI; Rice, AS; Sellaturay, S, 1998) |
| " In inflamed bladders, URB937 had a U-shaped dose-response curve; following an initial cannabinoid receptor type 1-mediated reduction in pain responses and normalisation of bladder reflex activity, URB937 gradually increased both pain responses and bladder reflex activity through the transient receptor potential ion channel subfamily V member 1." | 1.56 | Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats. ( Charrua, A; Cruz, F; Marczylo, T; Matos, R; Nagy, I; Oliveira, R, 2020) |
| "Cystitis was induced by cyclophosphamide in female rats." | 1.42 | Protective effect of palmitoylethanolamide in a rat model of cystitis. ( Aveta, T; Borrelli, F; Buono, L; Capasso, R; Di Marzo, V; Fiorenzani, P; Izzo, AA; Orlando, P; Pessina, F; Valacchi, G, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Charrua, A | 1 |
| Matos, R | 1 |
| Oliveira, R | 1 |
| Marczylo, T | 1 |
| Nagy, I | 1 |
| Cruz, F | 1 |
| Pessina, F | 1 |
| Capasso, R | 1 |
| Borrelli, F | 1 |
| Aveta, T | 1 |
| Buono, L | 1 |
| Valacchi, G | 1 |
| Fiorenzani, P | 1 |
| Di Marzo, V | 1 |
| Orlando, P | 1 |
| Izzo, AA | 1 |
| Jaggar, SI | 1 |
| Hasnie, FS | 1 |
| Sellaturay, S | 1 |
| Rice, AS | 1 |
3 other studies available for palmidrol and Cystitis
| Article | Year |
|---|---|
Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats.
Topics: Amides; Amidohydrolases; Animals; Arachidonic Acids; Cannabinoids; Cystitis; Endocannabinoids; Ethan | 2020 |
Protective effect of palmitoylethanolamide in a rat model of cystitis.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclophosphamide; Cystitis; Disease Models | 2015 |
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain.
Topics: Amides; Analgesics; Animals; Arachidonic Acids; Cannabinoids; Capillary Permeability; Cystitis; Elec | 1998 |